CSIMarket
 
Icad Inc  (ICAD)
Other Ticker:  
 
 
Price: $1.6400 $0.12 7.895%
Day's High: $1.64 Week Perf: 17.56 %
Day's Low: $ 1.56 30 Day Perf: 17.14 %
Volume (M): 106 52 Wk High: $ 2.65
Volume (M$): $ 174 52 Wk Avg: $1.55
Open: $1.56 52 Wk Low: $1.18



 Market Capitalization (Millions $) 43
 Shares Outstanding (Millions) 26
 Employees -
 Revenues (TTM) (Millions $) 16
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 1

Icad Inc
ICAD Inc. is a medical technology company headquartered in Nashua, New Hampshire. The company specializes in developing advanced cancer detection and radiation therapy treatment solutions. It primarily focuses on products and services related to improving cancer detection accuracy and treatment outcomes.

One of the major innovations offered by ICAD Inc. is its advanced imaging technology called PowerLook' TomoDetection'. This technology assists radiologists in identifying potential abnormal tissues in breast images with greater accuracy and efficiency, aiding in early detection of breast cancer.

ICAD Inc. is also known for its Xoft' Axxent' Electronic Brachytherapy (eBx') System', which offers a non-invasive and targeted radiation therapy solution for various types of cancer treatments, including breast, skin, and gynecological cancers. The system is designed to provide precise and localized radiation treatment, reducing potential side effects and improving patient comfort.

Overall, ICAD Inc. is dedicated to advancing the field of cancer detection and radiation therapy by providing cutting-edge technology solutions that enhance patient care and improve overall treatment outcomes.


   Company Address: 98 Spit Brook Road, Suite 100 Nashua 3062 NH
   Company Phone Number: 882-5200   Stock Exchange / Ticker: NASDAQ ICAD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

Advancing Breast Cancer Detection iCAD and Windsong Radiology Harness AI Technology

Published Mon, Jul 29 2024 12:00 PM UTC

In a significant development in the field of medical imaging, iCAD, a company specializing in artificial intelligence (AI) solutions, has announced a strategic commercial agreement with Windsong Radiology. This partnership marks the deployment of the ProFound AI Breast Health Suite, aimed at enhancing mammography capabilities through advanced AI-powered algorithms. Windsong ...

Icad Inc

Icad Inc Reports Loss on Weak Sales in Financial Interval Closing Mar 31, 20242.

Icad Inc, a global leader in AI-powered breast health solutions, has recently reported its financial and operating results for the three months ended March 31, 2024. The company showcased its ProFound Breast Health Suite of AI solutions at the Society for Breast Imaging annual symposium, including the highly anticipated ProFound Cloud, powered by Google Cloud and Google Health AI architecture. Additionally, iCAD's strategic partnership with Densitas aims to enhance and optimize breast cancer diagnostics, ultimately benefiting healthcare professionals and patients alike.
Despite these promising developments, Icad Inc has experienced some fluctuations in its stock performance. While the stock recorded a solid gain of 5.59% over the past 7 days, it declined by 5.59% during the month of May. Currently trading on the NASDAQ, the stock is -13.4% below its 52-week average.

Product Service News

iCAD Unveils Groundbreaking AI-Powered Breast Health Solutions and Partnerships at SBI Annual Symposium

Published Thu, Apr 11 2024 12:00 PM UTC

iCAD, Inc. (NASDAQ: ICAD), a globally recognized leader in AI-powered cancer detection solutions, is set to make a remarkable impression at the upcoming Society for Breast Imaging (SBI) annual symposium in Montreal, Canada. The company will showcase its ProFound Breast Health Suite of AI solutions, including the highly anticipated ProFound Cloud, powered by Google Cloud and ...

Partnership

iCAD and Densitas Join Forces to Drive Precision in Breast Health Care with AI-Powered Solutions

Published Tue, Apr 9 2024 12:00 PM UTC

In an industry-first collaboration, American clinical radiology and AI-powered cancer detection company, iCAD, Inc., has joined forces with Canadian medical technology company, Densitas, Inc., global leaders in operational AI-driven breast cancer screening systems. The groundbreaking partnership, announced on April 9, 2024, is set to elevate the resonance of precision health...

Clinical Study

Unveiling Hidden Risks: Harnessing AI to Detect Cardiovascular Disease from Mammograms

Published Mon, Apr 8 2024 8:29 PM UTC

Cardiovascular disease (CVD) remains the leading cause of death globally, necessitating the development of innovative technologies to enhance early detection and targeted prevention strategies. Recent studies presented at the American College of Cardiology (ACC) meeting have demonstrated the potential of iCAD's ProFound AI Suite in uncovering hidden heart disease risks by su...







Icad Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com